BRPI0509645A - comprimidos dispensáveis de deferasirox - Google Patents
comprimidos dispensáveis de deferasiroxInfo
- Publication number
- BRPI0509645A BRPI0509645A BRPI0509645-6A BRPI0509645A BRPI0509645A BR PI0509645 A BRPI0509645 A BR PI0509645A BR PI0509645 A BRPI0509645 A BR PI0509645A BR PI0509645 A BRPI0509645 A BR PI0509645A
- Authority
- BR
- Brazil
- Prior art keywords
- deferairox
- dispensable tablets
- dispensable
- tablets
- depherosirox
- Prior art date
Links
- PDBKAEPAMFPDAZ-UHFFFAOYSA-N 2-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1N1C(C=2C(=CC=CC=2)O)=NC(C=2C(=CC=CC=2)O)=N1 PDBKAEPAMFPDAZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- BOFQWVMAQOTZIW-UHFFFAOYSA-N deferasirox Chemical compound C1=CC(C(=O)O)=CC=C1N1C(C=2C(=CC=CC=2)O)=NC(C=2C(=CC=CC=2)O)=N1 BOFQWVMAQOTZIW-UHFFFAOYSA-N 0.000 abstract 1
- 229960001489 deferasirox Drugs 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPRIMIDOS DISPENSáVEIS DE DEFERASIROX. A presente invenção refere-se a comprimidos dispensáveis que compreendem como ingrediente ativo deferasirox ácido 4-¢3,5-bis(2-hidroxifenhl)-¢1 ,2,4!triazol-1-iI!benzóico ou sal farmaceuticamente aceitável do mesmo, em uma quantidade de 42% a 65% em peso por peso total do comprimido.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0408078.4A GB0408078D0 (en) | 2004-04-08 | 2004-04-08 | Organic compounds |
| PCT/EP2005/003674 WO2005097062A1 (en) | 2004-04-08 | 2005-04-07 | deferasirox DISPERSIBLE TABLETS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0509645A true BRPI0509645A (pt) | 2007-09-18 |
Family
ID=32320645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0509645-6A BRPI0509645A (pt) | 2004-04-08 | 2005-04-07 | comprimidos dispensáveis de deferasirox |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080312302A1 (pt) |
| EP (1) | EP1734924A1 (pt) |
| JP (1) | JP2007532509A (pt) |
| CN (1) | CN1997348A (pt) |
| AR (1) | AR048864A1 (pt) |
| AU (2) | AU2005230402A1 (pt) |
| BR (1) | BRPI0509645A (pt) |
| CA (1) | CA2559739A1 (pt) |
| GB (1) | GB0408078D0 (pt) |
| PA (1) | PA8629501A1 (pt) |
| PE (1) | PE20060717A1 (pt) |
| RU (1) | RU2396954C2 (pt) |
| TW (1) | TW200603841A (pt) |
| WO (1) | WO2005097062A1 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1945272T3 (pl) | 2005-11-01 | 2014-03-31 | Novartis Ag | Sposób prowadzenia scyntygraffi |
| JP2009536180A (ja) | 2006-05-09 | 2009-10-08 | ノバルティス アクチエンゲゼルシャフト | 鉄キレート剤と抗新生物剤を含む組合せ剤およびそれらの使用 |
| JP2009538329A (ja) * | 2006-05-23 | 2009-11-05 | ノバルティス・アクチェンゲゼルシャフト | 遺伝性ヘモクロマトーシスの処置方法 |
| CA2670313C (en) | 2006-11-29 | 2013-02-12 | Novartis Ag | Polymorphic forms of deferasirox (icl670a) |
| JPWO2010032489A1 (ja) | 2008-09-22 | 2012-02-09 | 国立大学法人旭川医科大学 | 鉄キレート剤及びその製造方法、並びに鉄イオンの定量・捕捉方法 |
| CA2805568A1 (en) | 2010-07-08 | 2012-01-12 | Ratiopharm Gmbh | Oral dosage form of deferasirox |
| PE20140166A1 (es) | 2010-10-01 | 2014-02-17 | Cipla Ltd | Composicion farmaceutica que comprende deferasirox |
| WO2012096183A1 (ja) | 2011-01-14 | 2012-07-19 | 株式会社ダステック | 高分子鉄キレート剤 |
| EP2916870A1 (en) | 2012-11-12 | 2015-09-16 | Cipla Limited | Fixed dose pharmaceutical composition comprising deferasirox and deferipone |
| HUE036921T2 (hu) | 2013-03-08 | 2018-08-28 | Novartis Ag | Orális deferasirox készítmények |
| RU2015149544A (ru) | 2013-05-10 | 2017-06-16 | Сипла Лимитед | Низкодозовая фармацевтическая композиция |
| EP2946771B1 (en) | 2014-05-20 | 2019-03-20 | Sanovel Ilac Sanayi ve Ticaret A.S. | Water-dispersible tablet formulation comprising deferasirox |
| EP2987482A1 (en) | 2014-08-22 | 2016-02-24 | Santa Farma Ilaç Sanayi A.S. | Soluble and dispersible pharamaceutical deferasirox formulation |
| WO2016167729A1 (en) | 2015-04-16 | 2016-10-20 | Öğün Yusuf Toktamiş | Dispersible tablets comprising deferasirox |
| CA3029543C (en) * | 2016-07-05 | 2021-11-23 | Jubilant Generics Limited | Immediate release pharmaceutical composition of iron chelating agents |
| EP3518904A1 (en) | 2016-09-30 | 2019-08-07 | Synthon B.V. | Pharmaceutical composition comprising deferasirox |
| CZ2017255A3 (cs) | 2017-05-04 | 2018-11-14 | Zentiva, K.S. | Filmem potažené tablety Deferasiroxu |
| WO2018208242A1 (en) | 2017-05-10 | 2018-11-15 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Formulation of deferasirox tablet for oral suspension composition with better processability |
| EP3675832A1 (en) | 2017-09-01 | 2020-07-08 | Jordan Sweden Medical and Sterilization Company | Fast self dispersible dosage forms of deferasirox |
| TR201722910A2 (tr) | 2017-12-29 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9215908D0 (en) * | 1992-07-27 | 1992-09-09 | Wellcome Found | Water dispersible tablets |
| DE4412117A1 (de) * | 1994-04-08 | 1995-10-12 | Fette Wilhelm Gmbh | Verfahren und Vorrichtung zum Aufbringen von pulverförmigem Schmier- oder Trennmittel auf die Preßwerkzeuge in Tablettiermaschinen |
| MY129541A (en) * | 1996-06-25 | 2007-04-30 | Novartis Ag | Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| EP1058538B9 (en) * | 1998-03-06 | 2013-01-02 | Aptalis Pharma S.r.l. | Fast disintegrating tablets |
| US6284270B1 (en) * | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
| EP1281264B1 (en) * | 2000-05-08 | 2012-12-12 | Broadcom Corporation | System and method for supporting multiple voice channels |
| WO2002069933A1 (fr) * | 2001-03-06 | 2002-09-12 | Kyowa Hakko Kogyo Co., Ltd. | Comprimés à délitement rapide dans la bouche |
| GB0223978D0 (en) * | 2002-10-15 | 2002-11-20 | Novartis Ag | Organic compound |
-
2004
- 2004-04-08 GB GBGB0408078.4A patent/GB0408078D0/en not_active Ceased
-
2005
- 2005-04-06 PE PE2005000383A patent/PE20060717A1/es not_active Application Discontinuation
- 2005-04-06 AR ARP050101362A patent/AR048864A1/es unknown
- 2005-04-07 US US11/547,243 patent/US20080312302A1/en not_active Abandoned
- 2005-04-07 BR BRPI0509645-6A patent/BRPI0509645A/pt not_active IP Right Cessation
- 2005-04-07 JP JP2007506730A patent/JP2007532509A/ja active Pending
- 2005-04-07 EP EP05733291A patent/EP1734924A1/en not_active Withdrawn
- 2005-04-07 RU RU2006139000/15A patent/RU2396954C2/ru not_active IP Right Cessation
- 2005-04-07 AU AU2005230402A patent/AU2005230402A1/en not_active Abandoned
- 2005-04-07 TW TW094111015A patent/TW200603841A/zh unknown
- 2005-04-07 WO PCT/EP2005/003674 patent/WO2005097062A1/en not_active Ceased
- 2005-04-07 CA CA002559739A patent/CA2559739A1/en not_active Abandoned
- 2005-04-07 CN CNA2005800121132A patent/CN1997348A/zh active Pending
- 2005-04-08 PA PA20058629501A patent/PA8629501A1/es unknown
-
2009
- 2009-04-28 AU AU2009201696A patent/AU2009201696A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200603841A (en) | 2006-02-01 |
| EP1734924A1 (en) | 2006-12-27 |
| GB0408078D0 (en) | 2004-05-12 |
| PA8629501A1 (es) | 2005-11-25 |
| CA2559739A1 (en) | 2005-10-20 |
| JP2007532509A (ja) | 2007-11-15 |
| US20080312302A1 (en) | 2008-12-18 |
| RU2396954C2 (ru) | 2010-08-20 |
| AU2009201696A1 (en) | 2009-05-21 |
| RU2006139000A (ru) | 2008-05-20 |
| AR048864A1 (es) | 2006-06-07 |
| WO2005097062A1 (en) | 2005-10-20 |
| CN1997348A (zh) | 2007-07-11 |
| PE20060717A1 (es) | 2006-08-02 |
| AU2005230402A1 (en) | 2005-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8586501A1 (es) | Tabletas dispersables que comprenden un derivado de acido benzoico | |
| GB0722077D0 (en) | Compounds | |
| AR048864A1 (es) | Tabletas dispersables que comprenden un derivado de acido benzoico | |
| BR0309528A (pt) | Comprimido com alta carga de droga | |
| ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
| ECSP088379A (es) | Tabletas dispersables que comprenden deferasirox | |
| CY1110097T1 (el) | Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων | |
| NO20072939L (no) | Makroloner - aminosubstituerte kinoloner | |
| ATE487720T1 (de) | 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer | |
| AT510866A3 (de) | Stabiles pharmazeutisches kombinationspräparat | |
| BRPI0407097A (pt) | Antagonista do casr | |
| MA33539B1 (fr) | Comprimé | |
| ECSP099382A (es) | Sulfonamidas heterocíclicos que tienen actividad antagonista edg-i | |
| WO2008123582A1 (ja) | テトラヒドロイソキノリン化合物 | |
| ECSP10010683A (es) | Una formulacion farmacéutica sólida | |
| MX2009005619A (es) | Formas poliformicas del deferasirox (icl670a). | |
| BRPI0509014A (pt) | comprimidos desintegráveis que compreendem licarbazepina | |
| ATE357220T1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung | |
| TW200607498A (en) | Agents for prevention or treatment of diseases associated with endothelial hyperproliferation | |
| TW200736270A (en) | Macrolones | |
| TH91425B (th) | การกำหนดสูตรใหม่ | |
| PY0742473A (es) | "Formulaciones fungicidas granuladas que contienen Carbendazim" | |
| UY28199A1 (es) | Nuevas composiciones antihelmínticas e insecticidas | |
| CR7539A (es) | Tableta con alto contenido de farmacos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |